The post Brevis (BREV) Joins Coinbase Markets’ Listing Roadmap, Expanding Zero-Knowledge Cross-Chain Data Access for dApps appeared on BitcoinEthereumNews.com. The post Brevis (BREV) Joins Coinbase Markets’ Listing Roadmap, Expanding Zero-Knowledge Cross-Chain Data Access for dApps appeared on BitcoinEthereumNews.com.

Brevis (BREV) Joins Coinbase Markets’ Listing Roadmap, Expanding Zero-Knowledge Cross-Chain Data Access for dApps

In a formal update, Coinbase Markets has confirmed that Brevis (BREV) has progressed onto its public listing roadmap. The zero-knowledge proof–driven cross-chain data-proof platform aims to empower dApps with secure access to on-chain data across multiple blockchains without reliance on trust in third parties.

Market observers note that this addition strengthens the credibility of cross-chain data solutions and could influence token visibility once listed. By emphasizing privacy-preserving proofs and data interoperability, the update highlights the potential for broader blockchain data access and developer productivity, while maintaining cautious risk controls. The development aligns with crypto markets‘ emphasis on transparent listings and credible technology narratives.

Source: https://en.coinotag.com/breakingnews/brevis-brev-joins-coinbase-markets-listing-roadmap-expanding-zero-knowledge-cross-chain-data-access-for-dapps

Market Opportunity
ZeroLend Logo
ZeroLend Price(ZERO)
$0.000008076
$0.000008076$0.000008076
-0.77%
USD
ZeroLend (ZERO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.